Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode

May 17, 2025 00:26:02
Episode Cover

Palliative Care in the ED

Approximately 75% of patients older than 65 years of age are seen in an ED within 6 months of their death.  While palliative care...

Listen

Episode 0

November 11, 2019 00:21:11
Episode Cover

The PrePARE Trial - Do IVFs Prevent Peri-Intubation CV Collapse?

Up to 25% of critically ill patients who undergo RSI and endotracheal intubation (ETI) may suffer cardiovascular collapse.? Many clinicians administer IVFs during RSI...

Listen

Episode 0

August 05, 2021 00:23:56
Episode Cover

Pigtail Catheters for Traumatic Hemothorax?

Traumatic hemothorax has traditionally been treated with a large bore thoracostomy to prevent retained hemothorax and morbidity.  In this podcast we discuss the results...

Listen